Publication | Open Access

The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma

1-Methylpropyl 2-Imidazolyl DisulfideMedicinePharmacologyPathologyVegf LevelsCancer BiologyAnti-cancer AgentOncologyCancer GrowthCancer ResearchCancer Patient Plasma